Filtros : "Indexado no Current Abstracts" "Universidade de Brasília (UnB)" Removidos: "IMPLANTES DENTÁRIOS" "in" "2013" Limpar

Filtros



Refine with date range


  • Source: BMC Cancer. Unidade: FORP

    Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, MORFOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RESENDE, Fernando F. B. et al. Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction. BMC Cancer, v. 16, n. 1, 2016Tradução . . Disponível em: https://doi.org/10.1186/s12885-016-2118-3. Acesso em: 12 out. 2024.
    • APA

      Resende, F. F. B., Bai, X., Del Bel, E. A., Kirchhoff, F., Scheller, A., & Titze-de-Almeida, R. (2016). Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction. BMC Cancer, 16( 1). doi:10.1186/s12885-016-2118-3
    • NLM

      Resende FFB, Bai X, Del Bel EA, Kirchhoff F, Scheller A, Titze-de-Almeida R. Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction [Internet]. BMC Cancer. 2016 ; 16( 1):[citado 2024 out. 12 ] Available from: https://doi.org/10.1186/s12885-016-2118-3
    • Vancouver

      Resende FFB, Bai X, Del Bel EA, Kirchhoff F, Scheller A, Titze-de-Almeida R. Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction [Internet]. BMC Cancer. 2016 ; 16( 1):[citado 2024 out. 12 ] Available from: https://doi.org/10.1186/s12885-016-2118-3
  • Source: Human Immunology. Unidade: FMRP

    Subjects: MUCOSA GÁSTRICA, INFECÇÕES POR HELICOBACTER, IMUNOHISTOQUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GENRE, J et al. HLA-G 14-bp Ins/Ins genotype in patients harbouring Helicobacter pylori infection: a potential risk factor?. Human Immunology, v. 83, n. 1, p. 52-57, 2015Tradução . . Disponível em: https://doi.org/10.1111/sji.12390. Acesso em: 12 out. 2024.
    • APA

      Genre, J., Reginaldo, F. P. S., Andrade, J. M. L., Lima, F. P., Camara, A. V. C., Donadi, E. A., & Crispim, J. C. (2015). HLA-G 14-bp Ins/Ins genotype in patients harbouring Helicobacter pylori infection: a potential risk factor? Human Immunology, 83( 1), 52-57. doi:10.1111/sji.12390
    • NLM

      Genre J, Reginaldo FPS, Andrade JML, Lima FP, Camara AVC, Donadi EA, Crispim JC. HLA-G 14-bp Ins/Ins genotype in patients harbouring Helicobacter pylori infection: a potential risk factor? [Internet]. Human Immunology. 2015 ; 83( 1): 52-57.[citado 2024 out. 12 ] Available from: https://doi.org/10.1111/sji.12390
    • Vancouver

      Genre J, Reginaldo FPS, Andrade JML, Lima FP, Camara AVC, Donadi EA, Crispim JC. HLA-G 14-bp Ins/Ins genotype in patients harbouring Helicobacter pylori infection: a potential risk factor? [Internet]. Human Immunology. 2015 ; 83( 1): 52-57.[citado 2024 out. 12 ] Available from: https://doi.org/10.1111/sji.12390
  • Source: Human Immunology. Unidade: FMRP

    Subjects: MUCOSA GÁSTRICA, INFECÇÕES POR HELICOBACTER, IMUNOHISTOQUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, D. M. B. O et al. Upregulation of soluble HLA-G5 and HLA-G6 isoforms in the milder histopathological stages of helicobacter pylori infection: a role for subverting immune responses?. Human Immunology, v. 83, n. 1, p. 38-43, 2015Tradução . . Disponível em: https://doi.org/10.1111/sji.12385. Acesso em: 12 out. 2024.
    • APA

      Souza, D. M. B. O., Genre, J., Silva, T. G. A., Soares, C. P., Rocha, K. B. F., Oliveira, C. N., et al. (2015). Upregulation of soluble HLA-G5 and HLA-G6 isoforms in the milder histopathological stages of helicobacter pylori infection: a role for subverting immune responses? Human Immunology, 83( 1), 38-43. doi:10.1111/sji.12385
    • NLM

      Souza DMBO, Genre J, Silva TGA, Soares CP, Rocha KBF, Oliveira CN, Jatobá CAN, Andrade JML, Moreau P, Medeiros AC, Donadi EA, Crispim JCO. Upregulation of soluble HLA-G5 and HLA-G6 isoforms in the milder histopathological stages of helicobacter pylori infection: a role for subverting immune responses? [Internet]. Human Immunology. 2015 ; 83( 1): 38-43.[citado 2024 out. 12 ] Available from: https://doi.org/10.1111/sji.12385
    • Vancouver

      Souza DMBO, Genre J, Silva TGA, Soares CP, Rocha KBF, Oliveira CN, Jatobá CAN, Andrade JML, Moreau P, Medeiros AC, Donadi EA, Crispim JCO. Upregulation of soluble HLA-G5 and HLA-G6 isoforms in the milder histopathological stages of helicobacter pylori infection: a role for subverting immune responses? [Internet]. Human Immunology. 2015 ; 83( 1): 38-43.[citado 2024 out. 12 ] Available from: https://doi.org/10.1111/sji.12385
  • Source: Journal of Applied Physics. Unidade: FFCLRP

    Subjects: NEOPLASIAS (TRATAMENTO), HIPERTERMIA, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FALQUEIRO, A. M. et al. Selol-loaded magnetic nanocapsules: a new approach for hyperthermia cancer therapy. Journal of Applied Physics, v. 109, n. 7, p. 07B306-1 - 07B306-3, 2011Tradução . . Disponível em: https://doi.org/10.1063/1.3556950. Acesso em: 12 out. 2024.
    • APA

      Falqueiro, A. M., Primo, F. L., Morais, P. C., Mosiniewicz-Szablewska, E., Suchocki, P., & Tedesco, A. C. (2011). Selol-loaded magnetic nanocapsules: a new approach for hyperthermia cancer therapy. Journal of Applied Physics, 109( 7), 07B306-1 - 07B306-3. doi:10.1063/1.3556950
    • NLM

      Falqueiro AM, Primo FL, Morais PC, Mosiniewicz-Szablewska E, Suchocki P, Tedesco AC. Selol-loaded magnetic nanocapsules: a new approach for hyperthermia cancer therapy [Internet]. Journal of Applied Physics. 2011 ; 109( 7): 07B306-1 - 07B306-3.[citado 2024 out. 12 ] Available from: https://doi.org/10.1063/1.3556950
    • Vancouver

      Falqueiro AM, Primo FL, Morais PC, Mosiniewicz-Szablewska E, Suchocki P, Tedesco AC. Selol-loaded magnetic nanocapsules: a new approach for hyperthermia cancer therapy [Internet]. Journal of Applied Physics. 2011 ; 109( 7): 07B306-1 - 07B306-3.[citado 2024 out. 12 ] Available from: https://doi.org/10.1063/1.3556950
  • Source: Journal of Applied Physics. Unidade: FFCLRP

    Subjects: NEOPLASIAS (TRATAMENTO), NANOPARTÍCULAS, HIPERTERMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PORTILHO, F. A. et al. Investigation of a magnetohyperthermia system efficacy. Journal of Applied Physics, v. 109, n. 7, p. 07B307-1 - 07B307-3, 2011Tradução . . Disponível em: https://doi.org/10.1063/1.3559498. Acesso em: 12 out. 2024.
    • APA

      Portilho, F. A., Estevanato, L. L. C., Miranda-Vilela, A. L., Almeida-Santos, M. F. M., Oliveira-Cavalcanti, C. E. de, Lacava, B. M., et al. (2011). Investigation of a magnetohyperthermia system efficacy. Journal of Applied Physics, 109( 7), 07B307-1 - 07B307-3. doi:10.1063/1.3559498
    • NLM

      Portilho FA, Estevanato LLC, Miranda-Vilela AL, Almeida-Santos MFM, Oliveira-Cavalcanti CE de, Lacava BM, Simioni AR, Tedesco AC, Morais PC, Lacava ZGM. Investigation of a magnetohyperthermia system efficacy [Internet]. Journal of Applied Physics. 2011 ; 109( 7): 07B307-1 - 07B307-3.[citado 2024 out. 12 ] Available from: https://doi.org/10.1063/1.3559498
    • Vancouver

      Portilho FA, Estevanato LLC, Miranda-Vilela AL, Almeida-Santos MFM, Oliveira-Cavalcanti CE de, Lacava BM, Simioni AR, Tedesco AC, Morais PC, Lacava ZGM. Investigation of a magnetohyperthermia system efficacy [Internet]. Journal of Applied Physics. 2011 ; 109( 7): 07B307-1 - 07B307-3.[citado 2024 out. 12 ] Available from: https://doi.org/10.1063/1.3559498
  • Source: Hyperfine Interact. Unidade: FFCLRP

    Subjects: ESPECTROSCOPIA DO MOSSBAUER, FÁRMACOS, NANOTECNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MORAIS, P. C. et al. Nanoscaled biocompatible magnetic drug-delivery system: preparation and characterization. Hyperfine Interact, v. 190, n. 1-3, p. 87-93, 2009Tradução . . Disponível em: https://doi.org/10.1007/978-3-642-01370-6_34. Acesso em: 12 out. 2024.
    • APA

      Morais, P. C., Garg, V. K., Oliveira, A. C., Silveira, L. B., Santos, J. G., Rodrigues, M. M. A., & Tedesco, A. C. (2009). Nanoscaled biocompatible magnetic drug-delivery system: preparation and characterization. Hyperfine Interact, 190( 1-3), 87-93. doi:10.1007/978-3-642-01370-6_34
    • NLM

      Morais PC, Garg VK, Oliveira AC, Silveira LB, Santos JG, Rodrigues MMA, Tedesco AC. Nanoscaled biocompatible magnetic drug-delivery system: preparation and characterization [Internet]. Hyperfine Interact. 2009 ; 190( 1-3): 87-93.[citado 2024 out. 12 ] Available from: https://doi.org/10.1007/978-3-642-01370-6_34
    • Vancouver

      Morais PC, Garg VK, Oliveira AC, Silveira LB, Santos JG, Rodrigues MMA, Tedesco AC. Nanoscaled biocompatible magnetic drug-delivery system: preparation and characterization [Internet]. Hyperfine Interact. 2009 ; 190( 1-3): 87-93.[citado 2024 out. 12 ] Available from: https://doi.org/10.1007/978-3-642-01370-6_34

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024